G6PC1 and ovarian carcinoma: Here again, silencing G6PC in ovarian cancer was associated with an accumulation of glycogen, a downregulation of PYGL (a regulator of glycogenolysis), a reduction in cell growth, and in an inhibition of the epithelial-to-mesenchymal transition (EMT) (23).